Old mice that were engineered to briefly and repeatedly switch on four “Yamanaka” genes, which can push cells toward a younger state, had less brain damage two days after a stroke than ordinary old mice, according to a study published on 1 November 2026 in the journal Aging Cell1. The treated mice also scored better on movement and balance tests, and the protective coating around their nerve fibers stayed in better shape1. The work was done only in mice, and the results cover the first 48 hours after the stroke1.
What happened
The researchers start from a simple problem. Aging comes with a decline in the brain’s ability to work and repair itself, and it is also the strongest risk factor for ischemic stroke, the kind caused by a blocked blood vessel1. This type of stroke remains a leading cause of death and long-term disability worldwide, and older brains tend to recover less well1.
The team asked whether “partial cellular reprogramming” could change how old brains cope with a stroke1. In plain words, that means switching on the four Yamanaka factors (known as Oct4, Sox2, Klf4 and c-Myc, or OSKM for short) for short periods, in repeated cycles1. The mice were built with a genetic on-off switch, which the paper calls a “Tet-ON” model, so the four genes could be turned on and off throughout the body1.
To cause the stroke, the researchers permanently blocked the middle cerebral artery, a major blood vessel feeding the brain1. They then compared the engineered mice with ordinary (“wild-type”) mice of the same age1. The paper describes the aim as testing “ischemic resilience”, meaning how well the brain withstands the loss of blood supply1.
The evidence so far
Forty-eight hours after the stroke, the mice whose Yamanaka genes had been switched on had a significantly smaller area of damaged brain than the ordinary mice1. They also had better scores on a standard check of nerve function, and did better on a tightrope test, where a mouse has to grip and cross a thin rope1. The authors say this suggests the animals kept more of their ability to sense and move1.
The team looked closely at myelin, the fatty insulation wrapped around nerve fibers that helps signals travel. In the ordinary mice, the stroke caused a marked loss of myelin1. In the treated mice, myelin stayed largely intact, judged both by a staining method called Black-Gold and by steady levels of two myelin proteins, MAG and MBP1.
Myelin is made and maintained by cells called oligodendrocytes. After the stroke, the treated mice had more of these cells overall, and more of the younger “precursor” cells that can mature into them1. The authors read this as a sign of a stronger repair response1.
Other measurements pointed the same way. The treated mice kept more nerve cells in the damaged outer layer of the brain1. They also did not show the strong activation of astrocytes, star-shaped support cells that react to injury, that was seen in the ordinary mice1. One thing did not differ: the response of microglia, the brain’s resident immune cells, was similar in both groups1.
What it does not show yet
This is a mouse study, and several limits stand out from what the paper reports.
- Short follow-up. The results reported are from 48 hours after the stroke1. The summary does not describe whether the mice stayed better off weeks or months later.
- Engineered animals, not a treatment. The genes were switched on in mice built for that purpose1. That is a way to study biology, not a therapy that could be given to a person after a stroke.
- Numbers not in the summary. The paper’s summary does not say how many mice were tested, so the size of the study cannot be judged from it.
- Timing. The study is framed around how well the brain withstands a stroke1. The summary does not spell out whether a similar effect would be seen if reprogramming started only after a stroke, which is when patients would be treated.
- Safety. Earlier work found that switching on Yamanaka factors could cause cancer in animals2, and reprogramming inside the body has led to disease and death from harsh side effects in some studies3. One of the four genes, c-Myc, is known for its cancer-causing potential3. The new summary does not report on these risks.
The authors call cyclic reprogramming “a promising strategy for enhancing brain resilience” during strokes1. That is their interpretation of mouse data; whether anything like it could help people is untested.
Who is behind it
The paper’s authors are P.R. Mallavibarrena, G. Martín-López, J. Rodríguez-Morales, J. Ávila, F. Hernández and M.J. Pérez-Álvarez1. Funding listed on the paper comes from the biology department of the science faculty at UAM, the Ministerio de Ciencia, Innovación y Universidades (a government science ministry), and two foundations, Fundación Tatiana Pérez de Guzmán el Bueno and Fundación Ramón Areces1. No company is listed among the funders in the record Biohack reviewed1.
How it fits the field
The four genes take their name from Shinya Yamanaka. In 2006, he and Kazutoshi Takahashi showed that these four genes alone could turn adult mouse connective-tissue cells back into a state like embryonic stem cells, able to become any cell type23. In 2011, a French team including Jean-Marc Lemaitre reported that cells from very old people, including people over 100, could be reset this way and then turned back into cells that looked young by their gene activity, telomeres and mitochondria2.
The catch is that fully resetting a cell makes it forget its job, which is not workable inside a living body2. Partial reprogramming tries to switch the genes on just long enough to turn back a cell’s age without erasing its identity3. In December 2016, a team led by Juan Carlos Izpisua Belmonte at the Salk Institute reported doing this in living mice: the genes were switched on when the animals drank the antibiotic doxycycline for two days, followed by a five-day rest2.
The brain has been a growing focus. A 2024 study in GeroScience delivered the four genes directly into the memory region of old female rats using viruses, and reported better performance on a maze-style memory test, although the treated rats still did not match young ones3. That study was small, with 8 treated and 6 control old animals in its aging-clock analysis3. Its authors cited David Sinclair’s team, which used three of the genes, leaving out c-Myc, in the eyes of mice3. Creating safe and effective reprogramming methods is still described as a work in progress3.
The new paper adds stroke to the list of brain conditions tested in animals, and it focuses on old mice, matching the age group most at risk1.
What to watch next
- Whether the full paper or later work tracks the mice for longer than two days, to see if the protection lasts and if recovery improves.
- Whether the effect appears when reprogramming starts after a stroke, rather than as built-in resilience.
- Whether other labs can repeat the result, and whether safety problems such as tumors show up with this approach.
- Whether gentler delivery methods, like the virus-based approach used in rats3, are tried for stroke.
Biohack will follow this thread as new results appear. This article is news, not medical advice.
